We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $767M
1-Year Est. Return 119.71%
This Fund
S&P 500
This Quarter Est. Return
+2.31%
1 Year Est. Return
+119.71%
3 Year Est. Return
+244.81%
5 Year Est. Return
+382.5%
10 Year Est. Return
+2,655.81%
AUM
$720M
AUM Growth
-$214M
Cap. Flow
+$56.8M
Cap. Flow %
7.89%
Top 10 Hldgs %
53.82%
Holding
93
New
36
Increased
15
Reduced
13
Closed
19

Top Buys

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$16.4M
2
BIIB icon
Biogen
BIIB
+$11.8M
3
ADBE icon
Adobe
ADBE
+$11M
4
PANW icon
Palo Alto Networks
PANW
+$10.9M
5
KRNT icon
Kornit Digital
KRNT
+$9.29M

Top Sells

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$32.5M
2
FIVN icon
FIVE9
FIVN
+$12.8M
3
ALT icon
Altimmune
ALT
+$11.7M
4
NICE icon
Nice
NICE
+$10.9M
5
JNJ icon
Johnson & Johnson
JNJ
+$10.2M

Sector Composition

Rank Sector Weight
1 Healthcare 66.85%
2 Miscellaneous 22.37%
3 Technology 7.17%
4 Industrials 1.24%
5 Consumer Discretionary 1.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FIVN icon
76
FIVE9
FIVN
$2.54B
– –
-140,968
Closed -$12.8M
FOLD
77
DELISTED
Amicus Therapeutics
FOLD
– –
-753,037
Closed -$8.09M
GNRC icon
78
Generac Holdings
GNRC
$12.2B
– –
-2,310
Closed -$530K
META icon
79
Meta Platforms (Facebook)
META
$1.72T
– –
-50,000
Closed -$8.06M
QQQ icon
80
CALL
Invesco QQQ Trust
QQQ
$482B
– –
-992,800
Closed -$278M
QQQ icon
81
Invesco QQQ Trust
QQQ
$482B
– –
-8,186
Closed -$2.47M
SPY icon
82
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$805B
– –
-199,500
Closed -$75.3M
V icon
83
Visa
V
$693B
– –
-12,600
Closed -$2.48M
VTGN icon
84
CALL
VistaGen Therapeutics
VTGN
$10.4M
– –
-50,000
Closed -$1.32M
VTGN icon
85
VistaGen Therapeutics
VTGN
$10.4M
– –
-109,705
Closed -$2.9M
XBI icon
86
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.6B
– –
-200,000
Closed -$14.9M
XBI icon
87
State Street SPDR S&P Biotech ETF
XBI
$10.6B
– –
-437,748
Closed -$32.5M
VINC
88
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
– –
-3,523
Closed -$93K
KNTE
89
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
– –
-91,673
Closed -$1.16M
ISEE
90
CALL
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-200,000
Closed -$1.92M
1 2 3
4

Similar funds

ISWM
Independent Solutions Wealth Management Williamsville, New York $766M AUM 31.53% 1-Year Est. Return
ACP
Albar Capital Partners London, United Kingdom $767M AUM 61.96% 1-Year Est. Return
NIM
Nexus Investment Management Toronto, Ontario, Canada $767M AUM 30.97% 1-Year Est. Return
ACM
Arvin Capital Management Austin, Texas $766M AUM 36.51% 1-Year Est. Return
CBT
Crews Bank & Trust Wauchula, Florida $766M AUM 19.5% 1-Year Est. Return
SPIA
Strategic Point Investment Advisors Providence, Rhode Island $767M AUM 17.58% 1-Year Est. Return
CNB
Camden National Bank Camden, Maine $767M AUM 14.32% 1-Year Est. Return
HI
Hendershot Investments Centreville, Virginia $766M AUM 10.81% 1-Year Est. Return

Sphera Funds Management's Q3 2022 Portfolio in Review

As of Q3 2022, Sphera Funds Management held 93 positions worth $720M, down 23% from $935M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Sphera Funds Management deployed $56.8M of net new capital in Q3 2022, opening 36 new positions and adding to 15 existing holdings. Its largest new stake was Biogen: 55,500 shares worth $14.8M.

By sector, the portfolio is most concentrated in Healthcare at 67% of assets, up from 48% a quarter earlier, followed by Miscellaneous and Technology.

On the sell side, the largest reduction was Altimmune, an estimated $11.7M trimmed.

  • Sphera Funds Management's largest Q3 2022 buy was Biogen: 55,500 shares worth $14.8M.
  • Sphera Funds Management added most to Sanofi in Q3 2022, an estimated $16.4M increase.
  • Sphera Funds Management's biggest Q3 2022 reduction was Altimmune, cutting an estimated $11.7M.
  • Sphera Funds Management fully exited State Street SPDR S&P Biotech ETF in Q3 2022, selling an estimated $32.5M.
  • Sphera Funds Management's ten largest holdings make up 54% of its $720M portfolio in Q3 2022.
  • Sphera Funds Management opened 36 new positions and closed 19 in Q3 2022.
  • Sphera Funds Management's portfolio value fell 23% quarter-over-quarter to $720M.

Based on Sphera Funds Management's 13F filing for Q3 2022, filed 14 Nov 2022.